The Physiology and Pharmacology of Dopamine Receptors: From Normal Signaling to Pathology
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Pharmaceutical Science".
Deadline for manuscript submissions: closed (28 October 2022) | Viewed by 11636
Special Issue Editor
Special Issue Information
Dear Colleagues,
The neurotransmitter dopamine, belonging to catecholamines, is an important molecule that activates two classes of receptors: D1-like and D2-like. Both these groups comprise more receptor subtypes: D1-like includes D1 and D5 dopamine receptors, and D2-like includes D2, D3 and D4 dopamine receptors. These groups also differ in signaling—while D1-like mostly activates adenylyl cyclase, D2-like receptors inhibit this enzyme. Dopamine receptors are expressed in many tissues in the organisms. In the central nervous system, they affect locomotion, they play a role in reward behavior, in neuroendocrine control, and in emotion. However, they also play an important role in the periphery: they have immunomodulatory effects in inflammatory diseases, they affect important functions of the cardio-pulmonary system, as well as renal functions. Pathologies in dopamine receptor, thus, have led to many diseases such as schizophrenia, addiction, Parkinson's disease, genetic hypertension and others. This Special Issue on “The Physiology and Pharmacology of Dopamine Receptors: From Normal Signaling to Pathology” will present a selection of original research papers or reviews that address these topics.
Prof. Dr. Jaromír Mysliveček
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- dopamine receptor
- signaling
- Parkinson’s disease
- addiction
- inflammation
- central nervous system
- peripheral dopamine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.